Frontier Medicines (@frontiermeds) 's Twitter Profile
Frontier Medicines

@frontiermeds

Frontier is a precision medicine company that has cutting-edge platform designed to generate medicines against previously undruggable disease-causing proteins.

ID: 1143555491060043777

linkhttps://frontiermeds.com/ calendar_today25-06-2019 16:24:10

43 Tweet

265 Followers

36 Following

Frontier Medicines (@frontiermeds) 's Twitter Profile Photo

We are excited to welcome Dr. Pamela Klein to our board of directors. Dr. Klein is a medical oncologist and senior biotechnology executive with over 20 years of experience who has advanced important cancer therapies to patients. #boardofdirectors

We are excited to welcome Dr. Pamela Klein to our board of directors. Dr. Klein is a medical oncologist and senior biotechnology executive with over 20 years of experience who has advanced important cancer therapies to patients.  #boardofdirectors
Frontier Medicines (@frontiermeds) 's Twitter Profile Photo

We’re excited to finally reconvene in person for this week’s 41st Annual J.P. Morgan Health Care Conference. If you are here, please join our CEO, Chris Varma, for his presentation. January 11, 2023, 10:00 a.m. PST #JPM23 #Biotech

We’re excited to finally reconvene in person for this week’s 41st Annual <a href="/jpmorgan/">J.P. Morgan</a> Health Care Conference. If you are here, please join our CEO, Chris Varma, for his presentation.  
January 11, 2023, 10:00 a.m. PST 
#JPM23 #Biotech
Frontier Medicines (@frontiermeds) 's Twitter Profile Photo

Kainat vividly recalls being the only girl at 4th grade math camp and advanced computing classes. Luckily for our Frontier™ Platform team, that only fueled her passion for STEM. This #February11, we applaud Kainat and all the #WomeninScience at Frontier and everywhere. #Biotech

Kainat vividly recalls being the only girl at 4th grade math camp and advanced computing classes. Luckily for our Frontier™ Platform team, that only fueled her passion for STEM. This #February11, we applaud Kainat and all the #WomeninScience at Frontier and everywhere. #Biotech
Frontier Medicines (@frontiermeds) 's Twitter Profile Photo

At 12, Kyle knew she wanted to be a scientist. Now, she is helping to discover new breakthroughs for patients. We are proud to support scientists, especially the #WomeninScience here at Frontier. Tomorrow is International Day of Women & Girls in Science! #February11 #Biotech

At 12, Kyle knew she wanted to be a scientist. Now, she is helping to discover new breakthroughs for patients. We are proud to support scientists, especially the #WomeninScience here at Frontier. Tomorrow is International Day of Women &amp; Girls in Science! #February11 #Biotech
Frontier Medicines (@frontiermeds) 's Twitter Profile Photo

Please join us in welcoming Christo as Frontier’s SVP and Head of Business Development! His global pharma background coupled with his leadership experience in growing biotechs will be invaluable as we continue on our rapid trajectory. bit.ly/welcomechristo #biotech

Please join us in welcoming Christo as Frontier’s SVP and Head of Business Development! His global pharma background coupled with his leadership experience in growing biotechs will be invaluable as we continue on our rapid trajectory. bit.ly/welcomechristo
#biotech
Frontier Medicines (@frontiermeds) 's Twitter Profile Photo

We are excited to join our colleagues in #biotech at #AACR23 in Orlando as we present updates on our lead candidate and the Frontier™ Platform. #oncology #chemoproteomics #undruggable rb.gy/hnkzbn

We are excited to join our colleagues in #biotech at #AACR23 in Orlando as we present updates on our lead candidate  and the Frontier™ Platform. #oncology #chemoproteomics #undruggable
rb.gy/hnkzbn
Frontier Medicines (@frontiermeds) 's Twitter Profile Photo

We are excited to join the oncology community this week at #AACR23 in Orlando as we present updates on our lead candidate and the Frontier™ Platform. #cancer

We are excited to join the oncology community this week at #AACR23 in Orlando as we present updates on our lead candidate and the Frontier™ Platform. #cancer
Frontier Medicines (@frontiermeds) 's Twitter Profile Photo

Today at #AACR23, we’re talking about the Frontier™ platform, which gives us the tools to open new frontiers in drugging the undruggable. Visit poster 5333 (Section 30, Board 15). Learn more here: frontiermeds.com/science-platfo…

Today at #AACR23, we’re talking about the Frontier™ platform, which gives us the tools to open new frontiers in drugging the undruggable. Visit poster 5333 (Section 30, Board 15). Learn more here: frontiermeds.com/science-platfo…
Frontier Medicines (@frontiermeds) 's Twitter Profile Photo

Decades after the human genome project, only 15% of the human proteome has approved treatments. We’re opening up new Frontiers in what is possible. Learn more here: frontiermeds.com/science-platfo… #DNADay #DNADay23 #biotech #chemoproteomics

Decades after the human genome project, only 15% of the human proteome has approved treatments. We’re opening up new Frontiers in what is possible. Learn more here: frontiermeds.com/science-platfo… #DNADay #DNADay23 #biotech #chemoproteomics
Frontier Medicines (@frontiermeds) 's Twitter Profile Photo

Are you at #BIO2023? Will the IPO market return? Join our CEO, Chris Varma, and leading experts in the field, as they discuss the current biotech financial climate. This afternoon at 2:15 p.m. ET Room 210A #standupforscience

Are you at #BIO2023? Will the IPO market return? Join our CEO, Chris Varma, and leading experts in the field, as they discuss the current biotech financial climate. This afternoon at 2:15 p.m. ET Room 210A #standupforscience
Sally Church (@maverickny) 's Twitter Profile Photo

A couple of important gems from the (over-crowded) poster halls really stood out for me this year at #AACR24. Will have some important clinical implications should the concept hold up in patients: bit.ly/49AXKGn

A couple of important gems from the (over-crowded) poster halls really stood out for me this year at #AACR24. 
Will have some important clinical implications should the concept hold up in patients: 
bit.ly/49AXKGn